| Monika Golebiowska-dal, PT | |
|
8426 Marco Ln, Baldwinsville, NY 13027-9182 | |
| (315) 380-6340 | |
| Not Available |
| Full Name | Monika Golebiowska-dal |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 8426 Marco Ln, Baldwinsville, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134906704 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 020867 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Monika Golebiowska-dal, PT 8426 Marco Ln, Baldwinsville, NY 13027-9182 Ph: (315) 380-6340 | Monika Golebiowska-dal, PT 8426 Marco Ln, Baldwinsville, NY 13027-9182 Ph: (315) 380-6340 |
News Archive
Imagine how different the lives of so many would be if diabetes were cured and the billions of dollars in annual health care costs that could be saved.
The new generation of incretin-based medicines will allow a coordinated action against the combination diabetes/obesity, also known as diabesity, in some cases with only a single weekly dose, and with the likelihood of additional beneficial effects on other health complications related to this condition, such as cardiovascular and neurodegenerative diseases.
Mouse models of human disease have made it possible to gain important insights into many conditions. However, many diseases remain for which no mouse model exists, and large proportion of human diseases without mouse models are associated with aging.
Medivation, Inc. and Astellas Pharma Inc. today announced treatment of the first patient in a second Phase 3 clinical trial of the investigational drug MDV3100, which expands the Phase 3 development of the novel, triple-acting oral androgen receptor antagonist into an earlier-stage patient population. Known as PREVAIL, the trial will evaluate MDV3100 in men with advanced prostate cancer who have not yet received chemotherapy. Initiation of the PREVAIL trial triggers a milestone payment to Medivation under its collaboration agreement with Astellas.
Many preventive measures for cognitive decline and for preventing Alzheimer's disease-mental stimulation, exercise, and a variety of dietary supplements-have been studied over the years. However, an independent panel convened this week by the National Institutes of Health determined that the value of these strategies for delaying the onset and/or reducing the severity of decline or disease hasn't been demonstrated in rigorous studies.
› Verified 7 days ago
Asad Emi, Physical Therapist Medicare: Medicare Enrolled Practice Location: 15 E Genesee St, Baldwinsville, NY 13027 Phone: 315-635-5000 | |
Advantage Physical Therapy Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 7 E Genesee St, Baldwinsville, NY 13027 Phone: 315-638-6428 Fax: 315-635-6024 | |
Michelle Scheiwiller, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 8483 Dunham Rd, Baldwinsville, NY 13027 Phone: 315-440-5847 | |
Kevin James Brown, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 19 E Genesee St, Baldwinsville, NY 13027 Phone: 315-635-5000 Fax: 315-635-3663 | |
Mrs. Leila C. Moore, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 19 E Genesee St, Baldwinsville, NY 13027 Phone: 315-635-5000 Fax: 315-635-3663 | |
Jennifer Lynn Monaco, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 8291 Luchsinger Ln, Baldwinsville, NY 13027 Phone: 315-303-4472 |